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Abstract
Natural killer (NK) cells play critical roles in innate immunity and in bridging innate and adaptive immune responses
against viral infection. However, the response of NK cells to monkeypox virus (MPXV) infection is not well
characterized. In this intravenous challenge study of MPXV infection in rhesus macaques (Macaca mulatta), we
analyzed blood and lymph node NK cell changes in absolute cell numbers, cell proliferation, chemokine receptor
expression, and cellular functions. Our results showed that the absolute number of total NK cells in the blood
increased in response to MPXV infection at a magnitude of 23-fold, manifested by increases in CD56+, CD16+,
CD16-CD56- double negative, and CD16+CD56+ double positive NK cell subsets. Similarly, the frequency and NK
cell numbers in the lymph nodes also largely increased with the total NK cell number increasing 46.1-fold. NK cells
both in the blood and lymph nodes massively proliferated in response to MPXV infection as measured by Ki67
expression. Chemokine receptor analysis revealed reduced expression of CXCR3, CCR7, and CCR6 on NK cells at
early time points (days 2 and 4 after virus inoculation), followed by an increased expression of CXCR3 and CCR5 at
later time points (days 7-8) of infection. In addition, MPXV infection impaired NK cell degranulation and ablated
secretion of interferon-γ and tumor necrosis factor-α. Our data suggest a dynamic model by which NK cells respond
to MPXV infection of rhesus macaques. Upon virus infection, NK cells proliferated robustly, resulting in massive
increases in NK cell numbers. However, the migrating capacity of NK cells to tissues at early time points might be
reduced, and the functions of cytotoxicity and cytokine secretion were largely compromised. Collectively, the data
may explain, at least partially, the pathogenesis of MPXV infection in rhesus macaques.
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Introduction
Monkeypox virus (MPXV), an emerging virus that could
cause up to 10% lethality in humans, poses a risk to human
health as an infectious agent and as a potential biological
weapon. Human MPXV infection resembles, in many aspects,
clinical symptoms of smallpox, including fever, weight loss,
lesions, and death [1,2]. To fully understand the pathogenesis
of MPXV and related orthopoxviruses, such as variola virus,
and to provide a model to evaluate countermeasures to these
poxviruses, a MPXV non-human primate (NHP) model has
been developed [3,4]. NHPs infected with MPXV have
symptoms resembling those of human monkeypox and
smallpox. Intravenous (IV) injection of high doses (~5 x 107
PFU) of MPXV led to 80% lethality in macaques and injection
of 5 x 106 PFU of MPXV resulted in survival of most macaques
(>80%) [3,4]. While most studies were focused on the
pathology and pathogenesis of MPXV, little is known about the
innate and adaptive immune responses to MPXV infection in
this model.
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Natural killer (NK) cells are a major arm of innate immunity
and play a critical role in anti-viral immune responses [5]. The
activation or inhibition of NK cells is initiated by interaction
between activating or inhibitory receptors on NK cells and their
ligands, such as major histocompatibility complex I (MHC-I)
molecules, on target cells [6,7]. NK cells exert their antiviral
protective role by direct killing of virus-infected cells and by
secreting cytokines to modulate functions of other cell types
such as T cells and dendritic cells (DCs) [8-10]. The killing
effect of NK cells is mediated by cell-cell interactions and by
secretion of granules containing perforin and granzymes [11].
Cytokines, such as interferon gamma (IFN-γ) and tumor
necrosis factor alpha (TNF-α), secreted by NK cells at early
stages of infection mediate inflammatory responses in inflamed
tissues and also coordinate with DCs to induce Th1 cell
polarization [12,13]. In both animal models and in humans, NK
cells are essential to controlling replication of some viruses,
such as herpes viruses in humans [14], murine
cytomegalovirus [15,16], human immunodeficiency virus (HIV)
[17], influenza viruses [18], and ectromelia virus (ECTV)
[19,20]. Depletion of NK cells in mice rendered mice more
susceptible to a number of viruses, such as murine hepatitis
virus, murine cytomegalovirus , and vaccinia virus (VACV), but
had no effect on susceptibility of mice to lymphocytic
choriomeningitis virus [21]. These data suggest that the relative
importance of NK cells in controlling virus invasion may vary
from virus to virus [22-24].
Studies on NK cell function in orthopoxvirus infections have
been primarily performed in mouse models. In the ECTV
orthopox model, C57BL/6 mice are naturally resistant to ECTV
via foot-pad inoculation. Previous data indicates that NK cells
are essential for protecting C57BL/6 mice from ECTV by direct
cytolytic function and by modulating T cell responses
[20,25,26]. By depleting NK cells at different time points after
ECTV infection, Fang and Sigal showed that NK cells are
required at early stage of infection (at and before day 4) to
control viral loads and confer resistance to ECTV infection [20].
Furthermore, aged C57BL/6 mice became susceptible to ECTV
infection owing to reduced NK cell number and compromised
trafficking of NK cells to lymph nodes (LNs) [27]. In addition to
ECTV, NK cells are also essential to curb the replication of
another orthopoxvirus, VACV [21-23]. However, the NK cells
during ECTV and VACV infection may use different
mechanisms to control replication of these viruses [22].
In humans, CD56 is commonly used as a NK cell marker.
However, CD56 is not specifically expressed on all NK cells,
but on subsets of NK cells in rhesus macaques [28]. Instead,
almost all NHP NK cells express CD8α and NKG2A, thus,
CD3-CD8+NKG2A is used as a reliable combination of markers
to identify NK cells in NHPs [29,30]. In addition, different
subsets of NHP NK cells can be classified by CD16 and CD56
expression on the cell surface. While the CD16+CD56- subset
(CD16+ NK cells) is the dominant subset (85-90%) in the blood
at steady state, a low frequency of CD16-CD56+ (CD56+),
CD16-CD56- (double negative, DN), and CD16+CD56+
(double positive, DP) NK cells also exist in circulating blood
[30,31]. Transcriptional analysis suggested that CD16+,
CD56+, and DN cells from rhesus macaques are distinct, but
inter-related NK cell subsets with each population having
unique, but also overlapping expression profiles such as
chemokine and cytokine receptors and transcriptional factors
[32]. Similar to human NK cells [33], NHP CD16+ NK cells
primarily exert cytotoxic function, and CD56+ cells are prone to
secrete cytokines. The DN cells have functions of both
cytotoxicity and secretion of cytokines [31,33,34]. Previous
studies in macaques have assessed NK cell numbers and/or
functions following challenge with other viruses. Peripheral NK
cell number decreased about 2-fold at 3-4 days post-
inoculation when rhesus macaques were infected with
lymphocytic choriomeningitis virus WE strain [35]. In studies
with Ebola and Marburg viruses in macaques, both viruses also
induced depletion of NK cells in the blood [36,37]. In studies
with simian immunodeficiency virus infection (SIV), acute
infection of NHPs with SIVmac251 resulted in activation and
increased lytic capacity of NK cells that appeared to be
associated with control of SIV infection [38]. In contrast, rhesus
macaques chronically infected with SIV displayed impaired
cytokine expression, but surface CD107a expression did not
change compared to uninfected NHPs [31].
In the current study, we assessed for the first time the
changes in NK cell numbers and phenotype in the blood and
lymphoid tissues of NHPs upon sub-lethal MPXV IV
inoculation. We also analyzed NK cell proliferation, the
expression patterns of cell surface chemokine receptor, and
NK cell functions. Our data indicate that MPXV infection
induced marked increases in NK cell numbers and cell
proliferation. However, the capacity of NK cells to migrate to
peripheral tissues might be reduced at early time points
following virus inoculation, as reflected by reduced chemokine
receptor expression on the surface of NK cells. Most
importantly, NK cells both in the blood and in the lymphoid
tissues displayed a compromised degranulation capacity and
lost almost all cytokine secreting potential.
Materials and Methods
Ethics statement
All animal experiments were approved by the National
Institute of Allergy and Infectious Diseases, Division of
Intramural Research, Animal Care and Use Committee (ACUC)
and adhered to National Institutes of Health (NIH) policies. The
entire procedure to handle NHPs including injections or
inoculations of virus, blood withdrawals, and biopsy and
necropsy strictly followed NIH NHP regulations and guidelines.
All animal handling and scientific procedures (e.g. virus
injection, blood withdrawal, and biopsy) were performed under
anesthesia with intramuscular injection of ketamine
hydrochloride 10-25mg/kg. Investigators and animal care
personnel provided additional comfort and care such as
supplemental heat and IV, SQ, or oral fluids, consistent with
the scientific integrity of the protocol. Animals that were not
eating were tube-fed under sedation. Such animals were given
metoclopramide 0.3 mg/kg IM 15 minutes prior to tube feeding
to prevent vomiting.
Animals were euthanized in accordance with the 2007
Report of The American Veterinary Medical Association Panel
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on Euthanasia utilizing exsanguination via direct cardiac
puncture subsequent to the induction of deep anesthesia by
intravenous injection of 100 mg/kg of sodium pentobarbital
(Fatal Plus®, Vortech Pharmaceuticals, Dearborn, MI). Death
was ensured by administration of sodium pentobarbital.
Animals, Virus Inoculation, and Sample Collection
MPXV Zaire 79 stocks were propagated in BSC-1 cells at a
multiplicity of infection (MOI) of 0.1 for 3 days. Virus inoculum
was crude virus prepared by 3 freeze/thawing cycles followed
by centrifugation and ultrasonic treatment, then pelleted over a
36% sucrose cushion.
The experimental design is outlined in Table 1. Rhesus
macaques (Macaca mulatta) of both sexes, ranging in weight
from 4–8 kg, were housed in biosafety level 3 (BSL-3) bio-
containment cages (Primate Products, Miami, FL). Such
macaques were acclimated to a 12:12 hour light/dark cycle in a
temperature and humidity controlled vivarium facility at NIH. All
animals were acclimated to the study facility for a minimum of 2
weeks prior to the start of the study. Prior to enrollment, NHPs
were screened and found to be seronegative for simian
retrovirus, simian T cell leukemia, VACV, cowpox virus, and
MPXV. Virus inoculations were performed by IV injection of
desired virus doses in 1ml of phosphate buffered saline (PBS).
At different time points before and after virus inoculation, blood
was collected aseptically in ethylenediaminetetra-acetic acid
(EDTA)-treated tubes. Blood samples were tested for changes
in standard clinical serum chemistry values, virus load, and
total cell counts of blood cell populations to monitor subject
health. Clinical signs were evaluated daily. Biopsies of axillary
LNs at day 5 and day 12 after virus inoculation in Experiment B
and complete necropsies at the end of each experiment were
performed following standard surgical procedures.
The data reported herein are results from two individual
experiments. Experiment A included six MPXV-infected NHPs
(2.5 x 106 PFU Zaire 79 strain) and two normal controls. We
performed the following analyses on samples from experiment
A: 1), chemokine receptor staining from peripheral blood
mononuclear cells (PBMCs) at different time points and LN
cells from days 8 and 9 necropsy samples; 2), NK cell
frequency and total NK cell number from whole blood and
day8/9 LNs; and 3), NK cell functional analysis (CD107a, IFN-
γ, TNF-α) from PBMCs and LN cell samples. In experiment B,
five NHPs were infected with 1.5 x 106 MPXV Zaire 79 strain
and another two NHPs served as uninfected controls. We
obtained the data for the total NK cell number in the blood and
the Ki67+ expression data in the blood and LNs (days 5 and
12) from Experiment B.
Reagents and antibodies
The following antibodies (Abs) and conjugates were
purchased from BD Pharmingen (San Jose, CA): CD3-Pacific
Blue, -Alexa Fluor® 700, -APC (SP34-2); CD8α-APC-H7 (SK1);
CD8α-Pacific Blue (custom conjugate, SK1); CD14-Pacific
Blue, -Alexa Fluor® 488 (M5E2); CD16-APC, -PE (3G8); CD45-
PerCP (D058-1283); CD56-PE-Cy7 (NCAM16.2); CD197
(CCR7)-Alexa Fluor® 647; CD183 (CXCR3)-PerCP-Cy5.5
(1C6); CD195 (CCR5)-APC (3A9); CD196 (CCR6)-PerCP-
Cy5.5 (11A9); human Ki67-PerCP-Cy5.5 (B56); CD107a-APC
(H4A3); INFγ-PerCP-Cy5.5 (B27); TNFα-V450 (Mab11); mouse
IgG2a-AlexaFluor® 647, -APC (G155-178); and mouse IgG1-
PerCP-Cy5.5 (MOPC-21). CD16-FITC (VEP13) was purchased
from Miltenyi Biotech (Auburn, CA). CD159a (NKG2A)-PE
(Z199) was obtained from Beckman Coulter (Miami, FL).
Yellow LIVE/DEAD® dye was purchased from Invitrogen
(Carlsbad, CA).
Preparation of cells from blood and LNs
EDTA blood was either treated with ammonium-chloride
(ACK) lysis buffer to obtain leukocytes or layered over Ficoll
density gradient to obtain PBMCs. To obtain leukocytes, 0.7 ml
of whole blood was suspended in 3 mL of ACK buffer
(Invitrogen, Carlsbad CA) for 2–3 min, centrifuged, and washed
twice with PBS containing 2% fetal bovine serum (FBS). For
the preparation of PBMCs, EDTA-blood was diluted 2-fold in
PBS, layered over Ficoll solution (Sigma-Aldrich, St. Louis,
MO), and centrifuged at 1000 x g at room temperature (RT) for
30 min. Then, the interface cell layer was collected and washed
twice with PBS+2% FBS. The PBMCs were either directly used
for flow cytometric staining or for NK cell functional assays.
To prepare cells from LNs, the axillary LN was placed in a
cell strainer in a petri-dish containing 10 mL of PBS with 2%
FBS. The tissues were gently ground with the tip of a syringe.
The cells were collected and washed twice with PBS containing
2% FBS for further analysis.
Surface and intracellular staining
To characterize NK cells and NK subsets, PBMCs or
leukocytes (0.5–1 x 106 cells) were incubated with a mixture of
antibodies (Abs) to cell surface markers for 15–20 min at RT.
Table 1. Overview of experimental MPXV IV challenge
protocols for experiments A and B.
Experiment
MPXV
Virus
Strain
Inoculation
(IV) dose
(PFUa)
No. of
NHPs
Blood
samples
(days)
Lymph
node
biopsy
(days)
Necropsy
study
endpoints
(days)
A Zaire79 2.5 x 10
6 6 0, 2, 4,7,8, 9 no 8, 9
A Normalcontrol 0 2
0, 2, 4,
7, 8, 9 no 8, 9
B Zaire79 1.5 x 10
6 5
0, 2, 5,
8, 12,
16, 21,
30
5, 12 30
B Normalcontrol 0 2
0, 2, 5,
8, 12,
16, 21,
30
5, 12 30
PFU = plaque-forming units
doi: 10.1371/journal.pone.0077804.t001
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For chemokine receptor staining, PBMCs were incubated at
37°C in RPMI-1640 medium containing 5% FBS for one hours
followed by staining of cells with Abs against chemokine
receptors at 37°C for one hour. Cells were then washed and
subsequently stained with antibodies against CD3, CD8, CD16,
CD56, and NKG2A for 30 min at RT. Then the cells were
washed with PBS+2% FBS and were suspended in BD FACS
lysing buffer (BD Biosciences, San Jose, CA) for 30–40 min to
inactivate potential viruses before data acquisition. For
intracellular staining, the cells were washed twice with PBS
+2% FBS, then fixed with Cytofix/Cytoperm (BD Biosciences)
for 30–40 min at RT. The cells were washed with BD Perm/
Wash, followed by incubation with Abs to Ki-67 or cytokines.
After washing with BD Perm/Wash, the cells were suspended
in Perm/Wash buffer and were acquired using a LSR-Fortessa
cytometer (Becton Dickinson, San Jose, CA). The data were
analyzed with Flowjo software (TreeStar Inc., Ashland, OR) or
with BD FACS Diva software (BD Biosciences).
Absolute NK cell counts in blood and axillary LNs
The absolute number of NK cells in the blood was obtained
in two steps. First, in BD Trucount™ tubes (BD Biosciences),
the absolute number of blood CD45+ leukocytes, CD3+, CD8+
and CD4+ T cells and B cells were obtained. In a second set of
tubes, blood cells were stained with markers to distinguish NK
cells and subsets including CD3, CD8, NKG2A, CD16, and
CD56. The absolute number of CD16+, DN, CD56+, and DP
subsets within the NKG2A gate was calculated based on the
absolute number of CD3-CD8+ population from the Trucount
tubes.
The absolute number of total live cells in each axillary LN
was obtained by Trypan Blue exclusion, and the frequency of
NKG2A+ NK cells within the lymphocyte gate was obtained by
flow cytometric staining. Then the total NK cells (NKG2A+) and
NK subset cell number were calculated based on the total LN
cell number and the frequency of NK cells and NK subsets in
the LNs.
NK cell functional assay
To analyze NK cell function, we adapted a method published
by Reeves et al. [31]. NK cells were enriched by depleting
CD3+ T cells with CD3+ T cell microbeads (Miltenyi Biotech
Auburn, CA). The resulting cell population contained less than
3% of CD3+ T cells. NK-enriched cells (1 x 106 cells) were co-
cultured with MHC-I negative human cell line 721.221 at a ratio
of 5:1 for 10–12 h at 37°C in 5% CO2 in serum-free medium,
Aim-V® (Life Technologies, Grand Island, NY). Cultures
containing phorbol myristate acetate (50 ng/mL) and ionomycin
(200 ng/mL) or medium alone served as positive and negative
controls, respectively. Anti–CD107a-APC (clone H4A3) was
added into the culture (1μL/mL) during the incubation period
and BD Golgiplug and Golgistop (BD Biosciences) were added
into the culture as manufacturer recommends. Following
overnight culturing, the samples were stained using surface
markers to reveal NK cells and NK subsets (CD3, CD8,
NKG2A, CD16, and CD56). The cells were then fixed and
permeabilized using BD Cytofix/cytoperm followed by
intracellular cytokine staining with Abs against IFN-γ and TNF-
α.
Quantification of viral load in the whole blood by qPCR
Viral load in whole blood was determined by quantitative
PCR (qPCR) after DNA isolation from 50 µl of whole blood
using Genfind v2 according to the manufacturer’s directions
(Agencourt, Danvers, MA) as described previously [39].
Results were calculated by reference to the standard curve,
multiplied by the appropriate dilution factor, and reported as
gene copies per ml. The lower limit of detection of the synthetic
oligo was 10 copies, while the upper limit was 1x108 gene
copies per ml. We set our limit of detection at 10,000 copies/ml
blood so that we were well within the standard deviations that
would account for dilution errors and extraction efficiencies.
Statistical analyses
Statistical and graphic analyses were completed using
GraphPad Prism software (GraphPad Software Inc, San Diego,
CA) and the R Project for statistical computing (R Core Team,
Vienna Austria). Most experiments were tested using repeated
measure two-way ANOVA with Bonferroni post-tests. Student t-
tests were also used in some analysis. P values less than 0.05
(p<0.05) were assumed to be significant in all analyses. All
analyses were verified using appropriate bootstrap and
permutation re-sampling tests [40,41] in situations where the
assumptions were not met for parametric T-tests and ANOVA
or for analogous nonparametric Mann-Whitney and Kruskal-
Wallis tests. Wherever needed, Bonferroni or Holm
adjustments for multiple tests were used. Statistical analysis for
the correlation between virus load and NK cell number was
using both Pearson correlation and Spearman rank correlation
test.
Results
Marked increases in peripheral blood NK cell frequency
and absolute numbers following MPXV challenge
Previous studies with MPXV challenge in NHPs reported that
MPXV infection induced lymphoid depletion and
lymphadenopathy [3,4]. This raises the question whether
MPXV infection induces changes in the number of lymphocytes
including NK cells in NHPs. From blood samples collected at
different time points (Table 1), the absolute numbers of
lymphocytes and NKG2A+ NK cells or CD3-CD8+ NK-enriched
cells were enumerated. The number of lymphocytes slightly
decreased from baseline to day 2 and day 4 and then
increased on average 3.0-fold at day 7 in experiment A (Figure
S1A) and 2.1-fold at day 8 in experiment B (Figure S1B). After
day 8, overall lymphocyte counts remained high in a range of
1.5-2-fold of the base line (Figure S1B). The baseline number
of NK cells in rhesus macaques from our study was 116 cells/μl
of blood (range from 26–232 cells/μl blood) (Figure 1A,
Experiment A). At days 2 and 4 after MPXV inoculation, the
absolute numbers of NK cells remained relatively unchanged.
NK cell counts began to increase at around day 5, and peaked
(average 2704 cells/μl blood) at day 7 after virus inoculation,
NK Cell Responses to Monkeypox Virus in Macaques
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representing an average increases of 23-fold over the baseline
counts. At day 8, the NK cell number started to decline, but
was still 17-fold higher than the baseline (Figure 1A).
Accordingly, the frequency of NK cells of the total lymphocyte
population rose from an average 4.7±2.3% at baseline to
41.4±7.0% at day 7 and 36.0±5.6% at day 8 (Figure 1B,
Experiment A). Results from experiment B confirmed the
kinetics of NK cell numbers with a peak at day 8, representing
an average increase from 5.7±2.6% of the total lymphocyte
population at baseline to 35.4 ±8.2% at day 8, followed by a
decline close to baseline at day 21 (Figure 1C, 1D). The
changes in NK cell numbers upon MPXV infection varied
markedly among individual NHPs. For example, NHP AT25S
showed a 48-fold increase (4969 cells/μl blood at day 7 versus
104 cells/μl blood at baseline), while NHP iD3 had only a 10-
fold increase (1627 versus157 NK cells/μl blood at day 7 or day
0, respectively) (Figure 1A).
We questioned if all NK subsets or specific subset(s)
increased in the blood following MPXV challenge. NK cell
subsets were distinguished based on CD16 and CD56
expression within the NKG2A+ NK cell gate (Figure 1E) [31].
The frequency of CD16+ NK subset within the total NK cell
population decreased from 78.7 ± 4.5% at day 0 to 28.8 ±
21.7% (p< 0.0001 ) at day 7 post MPXV inoculation (Figure
1F). The frequency of DN cells increased from 4.6 ± 2.7% to
41.4 ± 16.7% (p<0.0001), becoming the dominant NK cell
subset in the blood. In addition, CD56+ NK cells also increased
from 5.5 ± 2.4% to 19.4 ± 9.7% (p=0.18) and DP NK cell
frequency remained unchanged (10.7 ± 1.2% and 10.9 ± 8.5%,
p>0.05). The absolute number of all NK subsets at day 7
postinoculation significantly increased (p<0.001 or p<0.0001)
upon MPXV infection (Figure 1G). Among them, the DN
population showed maximal increase (around 100-fold). For
CD16+, CD56+, and DP NK cells, the increases were 8.1-, 71-,
and 30-fold on average (Figure 1G).
Increased NK Cell Numbers in Lymphoid Tissues
during MPXV Infection
We questioned if MPXV infection induced changes in NK cell
number and composition in the LNs. Our analysis showed that
the frequency of total NK cells among lymphocytes increased
about 8.4-fold from an average of 0.55% in control NHPs to
4.6% in MPXV-infected NHPs (Figure 2A). Accordingly, the
total number of NK cells per axillary LN dramatically increased
from an average of 1.1x106 cells in control NHPs to 50.7 x106
cells in MPXV-infected NHPs (Figure 2B). The magnitude of
change in NK cell numbers varied greatly among individual
MPXV-infected NHPs. For example, the total NK cell number
was 14.1 x106 per LN in one NHP and it was 147.5 x106 in
another NHP (Figure 2B).
Analysis of NK cell subsets in the axillary LNs from control
NHPs confirmed previous reports [31,42] that DN and CD56+
cells were the major NK cell subpopulations in the LNs of
uninfected NHPs (Figure 2A, B and C). At days 8–9 post-
inoculation, the CD16+ and DP NK cells in the LNs increased
at variable frequencies. For example in NHP iD3 (Figure 2C),
CD16+ population reached 29.3% of total NK cells and DP
cells accounted for 15% of total NK cells. However, in NHP
DE3V, the CD16+ and DP populations accounted for 5.26%
and 42.3% respectively, of the total NK cells. Across all MPXV-
infected NHPs, the change in CD16+ cell frequency was not
significant (p>0.05). DN cell frequency was reduced from
average of 50.6% in control NHPs to 20.3% in MPXV-infected
NHPs (p<0.01). CD56+ cell frequency remained unchanged
(p>0.05). Regardless the increase or decrease in cell
frequency, the absolute number of all subsets significantly
increased as a result of the marked increase of total NK cell
number in the LNs (p<0.01, p<0.001, or p<0.0001) (Figure 2B).
Of the four NK cell subsets, DP cells on average displayed the
greatest magnitude of increase. This increase in DP cells is
partially a consequence of the extremely high number of total
NK cells (147.5 x 106) and DP cells (60.1 x 106, 42.3% of total
NK cells) in NHP DE3V.
In comparing the NK cell increases in the blood and the LNs,
the magnitude of NK cell increases in the blood is not similarly
observed in the LNs for a given NHP. For example, NHP
AT25S in the blood had the highest NK cell number in the
group (Figure 1A), but the LN NK cell number was relatively
low compared to other NHPs (Figure S2). In contrast, NHP
DE3V had the highest NK cell number in the LN, but the NK
cell number in the blood in this NHP is relatively low (Figure S2
and Figure 1A).
Robust NK cell proliferation in the blood and LNs
following MPXV challenge
The marked increase of NK cells in the blood and LNs could
be largely due to cell proliferation. In a previous study in mice
infected with either MCMV or VACV, peripheral NK cells rapidly
proliferated and peaked at day 6 postinoculation [43]. Similarly,
ECTV infection also induced NK proliferation in mice [20]. To
assess NK cell proliferation in our study, we examined Ki67
expression in the NK cells from the blood and LNs. NK cells
from the blood of normal control NHPs and NHPs before virus
inoculation showed a low frequency of Ki67 staining (<5%), and
the Ki67 expression frequency at day 2 after virus inoculation
was similar to background (Figure 3A). However, at days 5–8
after MPXV inoculation, about 30% of NK cells in the blood
expressed Ki67 protein (Figure 3A), a time frame consistent
with previous reports [20,43] and with the NK cell number
change in the blood (Figure 1A). The frequency of Ki67+ cells
in the blood gradually reduced to baseline at days 21–30.
When we examined the proliferation of NK cell subsets, CD16-
negative cells in the blood including DN cells and CD56+ cells
dominantly expressed Ki67 protein (Figure 3B). While a low
frequency of CD16+ (~15-20%) and DP (~5-8%) populations
also expressed Ki67, the Ki67+ cells in these two populations
tended to express a low intensity of CD16 protein (data not
shown).
We next measured Ki67 expression in NK cells in LNs at
days 5 and 12 postinoculation and found that a higher
proportion of LN NK cells from the MPXV-infected NHPs at day
5 expressed Ki67 (average 26%) compared to NK cells from
control NHPs (average 7.9 %) (Figure 3C). In addition, day 5
LNs from infected NHPs seemed to have a higher frequency of
Ki67+ cells than day 12, supporting the notion that cell
proliferation peaked at an early stage of virus infection (Figure
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Figure 1.  MPXV infection induced increases in NK cell frequency and absolute number in the blood.  Kinetics of NK cell total
number (A, C) and frequency (B, D) in the blood from experiments A (A, B) and B (C, D), respectively. E) Gating strategy of NK cell
subsets from day 0 and day 7 after virus inoculation. F) Frequency of NK cell subsets within the total NK cell gate in the blood at day
7 after virus inoculation (bar represents the median frequency). G) Absolute number of NK cell subsets in the blood at day 7 (bar
represents the median NK cell number/µl of blood). Statistical analysis of F) and G) were computed using repeated measures two-
way ANOVA in Graph-pad Prism software with Bonferroni post-tests and only significant p values were shown (***p<0.001; and
****p<0.0001). Results were confirmed using bootstrap re-sampling test computed with the R project for statistical computing.
doi: 10.1371/journal.pone.0077804.g001
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Figure 2.  NK cell frequency and absolute number in LNs at days 8–9 after MPXV inoculation.  A) Frequency of total NK cells
in the LN lymphocyte gate and frequency of NK subsets in the NK cell gate. B) Total NK cell number and numbers of NK subsets in
the LN. Total NK cell number was calculated based on the frequency of NKG2A+ NK cells in the lymphocyte gate and the total live
cell number of individual LNs. The total number of NK cell subsets was calculated based on the frequency of each subset within the
NK cell gate and the total NK cell number in the LN. C) Dot-plot showing the marked variation of NK cell subset distribution in two
representative subjects induced by MPXV infection. Statistical analyses of A) and B) were computed using two-way ANOVA in
Graph-pad Prism software with Bonferroni post-tests and p values with significant change are shown (* p<0.05, **p<0.01, ***
p<0.001, **** p<0.0001). Results were confirmed using bootstrap re-sampling test computed with the R project for statistical
computing.
doi: 10.1371/journal.pone.0077804.g002
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3C, 3D) [20,43]. Similar to blood NK cells, LN CD16- NK cells
(DN and CD56+ NK cells) displayed higher Ki67 staining than
CD16+ (CD16+ and DP) cells (Figure 3D).
Delayed/reduced chemokine receptor expression on
NK cells following MPXV challenge
To study the potential of NK cells to migrate to infected
peripheral tissues upon MPXV infection, we assessed the
expression of chemokine receptors CXCR3, CCR5, CCR6, and
CCR7 on each NK cell subset. Similar to result from others
[31,44], our analysis of NK cells from pre-inoculation blood
showed that CD56+ cells (average 40%) and DN cells
( average 42%) were the major subsets expressing CCR5
(Figures 4A) . In contrast, only a very small proportion of
CD16+ and DP NK cells express a low intensity of CCR5. The
frequency of CCR5-expressing cells in all subsets remained
unchanged at day 2 after MPXV infection and unchanged for
CD16+, DN, and DP NK cells at day 4, but moderately
increased in CD56+ cells (from average 40 to 60%, p>0.05) at
day 4. At day 7, however the average frequency of CCR5-
expressing cells in all subsets largely increased but did not
attain a statistical significance (Figure 4A). In addition, the
intensity of CCR5 expression also increased at day 7 after
MPXV inoculation as shown in a representative NHP in Figure
4B. Interestingly, the CCR5-expressing cells in CD16+ and DP
population were CD16dim cells (low intensity of CD16
expression), suggesting the CD16dim population might be
preferentially recruited to tissues compared to CD16high NK
cells (Figure 4B).
Figure 3.  Proliferation of NK cells from blood and lymph nodes upon MPXV infection.  A) Frequency of Ki67+ NK cells within
the NKG2A+ NK cell gate. B) Frequency of Ki67+ NK cells in each NK subset from days 5, 8, and 12 blood samples. C) Ki67+ NK
cell frequency within the NKG2A+ cell gate from days 5 and 12 biopsies of LNs. D) Ki67+ cell frequency in each NK subset from
days 5 and 12 biopsies of LNs (bar represent the median frequency of Ki67+NK cells).
doi: 10.1371/journal.pone.0077804.g003
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Figure 4.  MPXV infection induced changes in the expression of chemokine receptors on blood NK cells.  PBMCs from
different time points following MPXV inoculation were stained for NK markers and chemokine receptors as described in the material
and methods. The chemokine receptor expression was revealed by gating on individual NK cell subsets. A) Expression kinetics of
CXCR3, CCR5, CCR6, and CCR7 on NK cell subsets following MPXV inoculation. B) Representative analysis of CCR5 expression
on NK cells at days 0 and day 7 post-inoculation. Statistical analyses were permutation re-sampling tests with Holm-adjusted p-
values computed using R (*p<0.05).
doi: 10.1371/journal.pone.0077804.g004
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CCR7 is the chemokine receptor required for T and NK cells
to home to LNs [45-47]. Similar to result from other reports
[31,46], our results showed that only CD56+ NK cells at steady
state expressed CCR7 (Figure 4A). Following MPXV infection,
the frequency of CCR7+ CD56+ cells gradually decreased from
78% at day 0 to 50–60% on days 2–4 and to a low or negative
frequency at days 7–8. MPXV infection did not induce a
distinguishable change on CCR7 expression in other three NK
populations that were negative at steady state and during
MPXV infection (Figure 4A).
CXCR3 has been shown to mediate the migration of effector
T cells and NK cells to lymphoid tissues and/or inflamed
tissues [48,49]. Consistent with reports from others, we found
that about 90% of circulating CD56+ NK cells and 40% of DN
cells expressed CXCR3 at steady state, but CD16+ and DP
cells did not express CXCR3 (Figure 4A). Following MPXV
inoculation, the frequency of CD56+ cells and DN cells that
expressed CXCR3 was first reduced (p<0.05 CD56+, p>0.05
DN) at days 2 and 4, and then largely recovered at days 7–8
(p<0.05 for DN cells). In addition, about 20-25% of CD16+ cells
and 60% of DP NK cells also expressed CXCR3at days 7–8.
The role of CCR6 in cell migration is less clear than the other
chemokine receptors. Some investigators indicated that CCR6
may play a role in recruiting NK cells to tissues [31]. Also
consistent with a previous report of SIV-infected macaques
[31], results from our data showed that various proportions of
NK subsets before virus inoculation express CCR6. MPXV
infection ablated CCR6 expression on all four NK cell subsets
(Figure 4A).
We further analyzed chemokine receptor expression on NK
cells in the axillary LNs from control NHPs and from NHPs at
necropsy days 8–9 following MPXV inoculation. In control
NHPs, about 45–80% of all four NK subsets from LNs
expressed CCR5, CCR6, and CXCR3, and only CD56+ and
DP cells expressed CCR7 (Figure 5). Upon MPXV infection,
CCR5-expressing NK cells greatly increased (p<0.01) and
almost all LN NK cells expressed CCR5 (Figure 5). LN CD16+
and DN NK cells did not express CCR7 at steady state and
during MPXV infection. However, the CCR7-expressing cells in
CD56+ and DP population were markedly reduced (p<0.01)
upon MPXV infection, a result consistent with that from blood
NK cells. The expression of CXCR3 did not change in CD16+
and DN cells during MPXV infection, but slightly decreased in
CD56+ and DP cells (p>0.05). Similar to circulating NK cells,
almost all NK cells in the LN lost CCR6 expression following
MPXV infection.
Reduced CD107a expression and ablated cytokine
secretion by NK cells
We next asked whether MPXV infection induces any
changes in NK cell functions, including cytotoxicity capacity
and secretion of cytokines. We assessed the expression of
Figure 5.  MPXV infection induced changes in chemokine receptor expression on NK cells in LNs.  Frequency of chemokine
receptor expression on NK cell subsets from the axillary LNs of day 8-9 MPXV-infected NHPs. Statistical analyses were permutation
re-sampling tests with Bonferroni-adjusted p-values computed using R (**p<0.01).
doi: 10.1371/journal.pone.0077804.g005
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CD107a, a molecular marker for degranulation and cytotoxicity
[50,51], and intracellular expression of IFN-γ and TNF-α.
Enriched NK cells from blood and LNs were stimulated with
MHC-I-devoid cell line 721.221, and the expression of surface
CD107a and intracellular cytokines were measured. Consistent
with published reports [31], circulating CD16+ NK cells from
control NHPs expressed CD107a and barely expressed IFN-γ
and TNF-α (Figure 6), supporting their major role in killing
infected cells. DN cells, on the other hand, displayed strong
expression for both CD107a and cytokines. It is believed that
CD56+ NK cells are specialized to produce cytokines, such as
IFN-γ and TNF-α [31,33] and our data from normal LN control
NK cell cultures support the cytokine production role of CD56+
NK cells by showing that about 20% of CD56+ cells stained
positive for IFN-γ and TNF-α (Figure 6). However, we also
observed that 20% of CD56+ NK cells from the normal LN
culture expressed CD107a. Similar to the NK cells in the blood,
DN cells from the normal control LNs expressed both CD107a
and cytokines. Upon MPXV infection, the frequency of
CD107a-expressing CD16+ cells from the blood and the
CD56+ cells from the LN remained unchanged. However,
CD107a expression in the DN cells from both blood and LNs
was significantly reduced (p<0.01). Most strikingly, almost all
the NK cells, regardless of the source (blood and LNs) and
subset, lost their capacity to express both IFN-γ and TNF-α,
indicating a crippled NK cell cytokine response following MPXV
infection.
Clinical signs, virus load, and circulating NK cell
responses
NHPs in both experiments A and B received a sub-lethal
dose of MPXV and all NHPs survived through each individual
study end point (Table 1). In general, all NHPs developed
typical clinical signs of MPXV infection including fever, weight
loss and skin lesions [4]. No apparent difference was observed
regarding the clinical measurements (CBC/diff and serum
chemistry) and clinical signs among the NHPs from both
experiments. No clear correlation between the maximal lesion
number and the peak NK cell number at day 7-8 was
established (R=0.7 and p=0.233, data not shown). Virus load
(viral DNA copy number measured by qPCR) was used in
previous studies as a parameter to predict disease progression
[52,53]. Our studies using qPCR test of whole blood samples
showed the onset of positive MPXV DNA was from days 2-7,
roughly paralleling the increases in NK cell number and
lymphocyte number in the blood. Viremia lasted from a few
days to 10-11 days (data not shown). The peak MPXV genome
copies varied among individual NHPs and between the two
experiments (Table 2). One out of six NHPs from experiment A
and two out of four NHPs from experiment B were MPXV
negative at all time-points. The sample from NHP DC98 was
contaminated and thus not included in analysis. Statistical
analysis showed no clear correlation between virus load and
NK cell number (p>0.05, data not shown).
Discussion
We report for the first time the kinetics of NK cell responses
to MPXV infection in the rhesus macaque model. Previous
study with ectromelia virus-infected mice showed only a
modest increase in NK cell number (2–4 fold) following viral
infection [22]. Our results with MPXV infection in NHPs showed
a much greater increase in NK cell number both in the blood
(23-fold) and in LNs (46.1-fold). In addition, MPXV induced a
greater increase in NK number compared to that of the total
lymphocytes (23-fold versus 3-fold). These data and the
Figure 6.  Compromised NK cell functions upon MPXV infection.  Frequency of the expression of CD107a, IFN-γ, and TNF-α by
different NK cell subsets from day 8-9 blood and LN samples is shown. Calculation of mean frequency of expression from control
(dotted line) and MPXV-infected NHPs (solid line) was performed with Prism. Statistical analyses were permutation re-sampling
tests with Bonferroni-adjusted P-values computed using R (**p<0.01).
doi: 10.1371/journal.pone.0077804.g006
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observation that lymphadenopathy is the hallmark of MPXV
infection [54,55] prompt a question whether the robust NK cell
proliferation and the marked increase in NK cell number
induced by MPXV infection is unique to MPXV. It is possible
that MPXV expresses specific proteins or peptides to either
directly bind NK cell activating receptors to trigger activation
signals or reduce inhibitory signals by altering/reducing the
interaction of NK cell inhibitory receptors and their ligands such
as by down-regulating MHC-I expression. Previous studies
have shown that several viruses including ECTV and VACV
express specific proteins to bind/modulate NK cell receptors
and to induce NK cell proliferation and activation
[8,18,22,56-58]. However, the difference in the magnitude of
the NK cell response to challenge with MPXV and ECTV could
also be due to differences in animal species studied (mouse
versus rhesus macaques). Further experiments should
compare the NK cell responses induced by MPXV to that
induced by other poxviruses such as cowpox viruses and
variola virus in NHPs.
In our study, marked variation was observed in the changes
in NK cell number both in the blood and in LNs among
individual NHPs. However, when the overall changes in NK cell
number both in the blood and LN in an individual NHP are
compared to other NHPs, it is difficult to determine the
individual NHP that had the strongest overall NK response. The
different changes of NK cell number in the blood and LNs is
possibly related to differential recruitment of NK cells from and
to the lymphoid tissues or other tissues to or from the blood. If
a true marked variation in NK cell response between NHPs
exists, this variation could be largely due to difference in
genetic polymorphism and polygenic of NK cell receptors
[8,59,60]. In addition, individual immunological environment in
the NHP such as different immune cell compositions and the
baseline cytokine concentration may also play a role.
The marked increases of blood NK cells were manifested by
increases of all four NK cell subsets with DN cells showing the
Table 2. Peak virus load and peak NK cell number in the
circulating blood.
ExperimentsNHPs
Log10 peak
viral genome
copies/ml of
blood
Day of
peak virus
load  
Peak NK cell
number/µl of
blood
Day of peak
NK cell
number
 AT25S OOR* NA**  4946 7
 CG3J 4.82 9  1840 7
A DE3V 5 8  2005 7
 HDX 4.65 7  3531 7
 iD3 4.35 7  1627 7
 XAV 4.07 7  2856 8
 A5E068 OOR NA**  1563 8
 BDW5 6.86 12  1802 8
B DC90 5.75 12  2897 8
 E06 OOR NA**  1593 8
OOR, out of range low; ** NA, not available; NHP DC98 in experiment B was
excluded for analysis
doi: 10.1371/journal.pone.0077804.t002
highest increases. In addition, the composition of NK cell
subsets in the circulating blood and in the LNs also largely
altered. In addition to CD16+ subset, DN and CD56+ cells also
become prominent populations in the blood. In the LNs, all four
NK subsets co-exist. These data indicate a very dynamic/
versatile NK cell response and probably overlapping roles
among the different subsets of NK cells during MPXV infection.
In future analysis, inclusion of multiple NK cell markers is
necessary to provide a global picture of the response.
Results from previous studies showed that CD56+ human
NK cells proliferated more vigorously than CD16+ cells upon
activation, and CD56+ NK cells can differentiate into CD16+
cytotoxic NK cells [61]. In our study, we showed that both
CD56+ cells and DN cells from blood and LNs displayed the
highest level of Ki67 expression, and CD16+ cells had little
Ki67 expression. These data suggest that proliferating CD56+
cells may differentiate into transitional DN NK cells, then
terminally into cytotoxic CD16+ cells. The increases in CD16+
NK cell number in the blood and LNs and the demonstration
that DN cells are potent in both cytotoxicity and secretion of
cytokines support this hypothesis. Therefore, we speculate that
these transitional DN cells are an important cell population that
exerts multiple NK cell functions.
To exert their antiviral functions, blood NK cells need to be
recruited to infected tissues, a process mediated by chemokine
receptors, chemokines, and adhesion molecules. Except for an
increase in CCR5 expression at day 4 in CD56+ blood NK
cells, most blood NK cell subpopulations had a reduced/low
frequency of chemokine receptor expression during early
MPXV infection. The low number of some blood NK subsets
(DN, CD56+, DP NK cells) and the generally low and/or
reduced frequency of expression of chemokine receptors on
these cells during early MPXV infection indicate that NK cells
have a very limited capacity to migrate to peripheral tissues.
At days 7/8 post-inoculation, the expression of CXCR3 and
CCR5 was recovered and/or increased on majority of blood NK
cells. In contrast, almost all NK cells lost their expression of
CCR7 and CCR6, indicating that CXCR3 and CCR5 mediated
the migration of NK cells into peripheral tissues. Our data are
consistent with a previous study that showed NK cell entry into
stimulated LNs is mediated by CXCR3 rather than by CCR7,
although recruitment of NK cells under normal conditions
depends on CCR7 [13]. In addition, our data also support
previous conclusion that CCR5 is a critical chemokine receptor,
guiding NK cell trafficking to infected tissues where NK cells
induce inflammatory responses, kill infected cells, and
modulate adaptive immune responses [62-64]
Several caveats of our study include lack of assessment of
the expression of other important chemokine receptors that
also mediate NK cell recruitment, such as CX3CR1 on CD16+
NK cells [44,65] and the analysis of expression gradients of
chemokines in individual tissues. Lack of these data limits us
from providing a precise picture of the kinetics of NK cell
migration. Therefore, we conclude that our chemokine receptor
analysis only indicates the potential of NK cells to migrate to
peripheral tissues at day 7/8 following MPXV infection.
Assuming NK cells successfully migrated into the inflamed
tissues at day 7/8 following MPXV infection, do they actually
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exert their supposed functions? Our results showed that the
major NK cell population in the blood at day 7/8, DN cells, had
a reduced CD107a expression, an indication of a compromised
cytotoxicity. More strikingly, almost all NK cells lost their
cytokine secretion capacity. This result is in stark contrast to
results from the study with ECTV in C57BL/6 mice where
ECTV infection induced both NK cell activation, cell
proliferation, IFN-γ secretion, and cytotoxicity [22]. The ablation
of cytokine expression by MPXV infection could have serious
consequences. First, compromised IFN-γ production may
directly reduce the capacity of NK cells to clear MPXV-infected
cells as both IFN-γ and perforin are required to clear ECTV
[22]. Secondly, full battle of the immune system against virus
infection requires the collaboration of different arms of
immunity such as T cell responses and virus-specific Abs to
handle large virus loads. NK cells play a key role in initiating
and shaping adaptive immune response, especially T cell
responses by collaborating with DCs and by secreting
cytokines [13]. One can speculate that the deficiency of
cytokine secretion by NK cells could result in delayed/reduced
T cell activation and the following B cell activation [66-68].
All NHPs in our experiments were treated with a sub-lethal
dose of virus and survived through the study endpoints. All
NHPs developed typical clinical signs of MPXV infection and no
clear difference on the clinical signs was observed among the
NHPs. However, three out of ten NHPs had no detective virus
DNA and the NHPs with positive MPXV DNA showed marked
variation in the onset, duration and magnitude of viral genome
copies, making it difficult to establish a clear correlation
between virus load and NK cell responses statistically.
Although the potential of NK cell migration at early time points
was reduced and NK cells lost their cytokine secreting activity,
the large increase of NK cell number, the recovery of
chemokine receptor expression at day 7/8 and the relatively
normal or partially reduced CD107a expression on NK cells
indicates that NK cells preserved, at least partially, their
function such as killing capacity, thus may contributing to the
final virus clearance. However, this NK cell killing effect may be
limited when lethal doses of virus are injected. From our
studies, we cannot rule out the possibility that other factors also
play important role in limiting virus replication and virus load.
Those factors may explain why we observed marked variation
in virus load and the virus load did not correlate with NK cell
response.
In summary, our data depict a complex scenario on the
evolution of MPXV-induced NK cell response. NK cell
responses to MPXV infection are controlled at multiple levels
such as increased NK cell number in the blood and in the
lymphoid tissues, capacity to be recruited to infected tissues,
and NK cell cytotoxicity and secretion of cytokines. Our data
suggest reduced migration of NK cells to tissues at early stage
of MPXV infection. We also found a dynamic change in the
expression of chemokine receptors on NK cells during MPXV
infection. At resting stage, CCR7 mediates the recruitment and
retention of NK cells in the LNs [42]. However, CCR5 and
CXCR3 could be the major receptors mediating recruitment of
NK cells to lymphoid tissues during MPXV infection. MPXV
infection also induced reduction of NK cell cytotoxicity and
ablated NK function to secrete cytokines. Taken together,
although MPXV induced massive NK cell proliferation and
increases in NK cell number, the cell migration and function
were reduced or even completely ablated. This may be a
causal reason why most NHPs succumb to MPXV infection
following high doses of MPXV infection.
Supporting Information
Figure S1.  MPXV infection induced increases in total
lymphocyte number in the blood. The absolute number of
total lymphocytes in the blood from experiment A (A) and
experiment B (B) were determined with BD Trucount tubes.
Total lymphocyte was gated based on Forward scatter and
CD45 expression.
(TIF)
Figure S2.  NKG2A+ NK cell numbers in LNs of individual
NHPs at day 8-9 post MPXV inoculation. Total NK cell
number was calculated based on the frequency of NKG2A+ NK
cells in the lymphocyte gate and the total live cell number of
individual LNs.
(TIF)
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